Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Jacobs, Ian; Menon, Usha; Ryan, Andy; Gentry‐Maharaj, Aleksandra; Burnell, Matthew; Kalsi, Jatinderpal; N. Amso, Nazar; Apostolidou, Sophia; Benjamin, Elizabeth; Cruickshank, Derek; N Crump, Danielle; K Davies, Susan; Dawnay, Anne; Dobbs, Stephen; Fletcher, G.; Ford, Jeremy; Godfrey, Keith; Gunu, Richard; Habib, Mariam; Hallett, Rachel; Herod, Jonathan; J. Jenkins, Howard; Karpinskyj, Chloe; Leeson, Simon; Lewis, Sara; R Liston, William; Lopes, Alberto; Mould, Tim; Murdoch, John; Oram, David; J. Rabideau, Dustin; Reynolds, Karina; Scott, Ian; W. Seif, Mourad; Sharma, Aarti; Singh, Naveena; Taylor, Julie; Warburton, Fiona; Widschwendter, Martin; Williamson, Karin; Woolas, Robert; Fallowfield, Lesley; McGuire, Alistair; Campbell, Stuart; Parmar, Mahesh; J. Skates, Steven

doi:10.1016/s0140-6736(15)01224-6

Public

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Published in The Lancet • Dec 18, 2015

Authors:

Ian Jacobs

Usha Menon

Andy Ryan

Abstract

BACKGROUND: Ovarian cancer has a poor prognosis, with just 40% of patients surviving 5 years. We designed this trial to establish the effect of early detection by screening on ovarian cancer mortality. METHODS: In this randomised controlled trial, we recruited postmenopausal women aged 50-74 years f...

Subject

Ovarian cancer

Medicine

Cancer

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!